Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet
Print
Robert Connor, PhD
Senior Principle Scientist I
Halozyme Therapeutics, Inc.
Poster(s):
(T0930-01-05) Preclinical Subcutaneous Injectability and Local Tolerability of an Antibody-Drug Conjugate Delivered with Recombinant Human Hyaluronidase PH20 Using a Handheld High-Volume Auto-Injector
Tuesday, May 6, 2025
9:30 AM – 10:30 AM
ET
Email Robert
